BACKGROUND: Metabolic syndrome, obesity and type 2 diabetes are metabolic disorders characterized by the insulin resistance and the impairment in the insulin secretion. Since impairment in the oxidative stress and adipocyte metabolism contribute to the formation of obesity and diabetes, targeting adipose tissue can be considered as an effective approach to fight against them. Rosiglitazone is used for treatment for patients with type 2 diabetes via inducing lipogenesis and transdifferentiation of white adipose tissue into brown adipose tissue. Since the development of such therapeutics is required to control the formation and function of brown fat cells, we aimed to reveal possible molecular mechanisms behind rosiglitazone induced biochemical changes in the adipose tissue. METHODS: Cells were expanded in the adipocyte culture medium supplemented with 5 µg/mL insulin following 2 days' induction. After those cells were treated with rosiglitazone 0, 0.13 mol/L and 10 µmol/L rosiglitazone for 48 hours and at 8th day, cells were collected and stored at -80 °C. Then the cells were used to evaluate antioxidant enzyme activities, mineral and trace element levels and fatty acid composition. RESULTS: Glucose-6-phosphate dehydrogenase and glutathione reductase significantly reduced in rosiglitazone-treated groups compared to the control. Na, Mg, K, Ca, Cr, Fe, Ni, Cu, Zn, Rb, Sr, Cs, Ba and Pb were determined in the cell lysates via ICP-MS. Also, relative FAME content decreased in the rosiglitazone-treated groups compared to the control. CONCLUSIONS: Rosiglitazone treatment at low doses showed promising results which may promote brown adipose tissue formation. 2020 Duygu Aydemir, Ehsan Sarayloo, Ulusu Nuriye Nuray, published by CEON/CEES.
BACKGROUND: Metabolic syndrome, obesity and type 2 diabetes are metabolic disorders characterized by the insulin resistance and the impairment in the insulin secretion. Since impairment in the oxidative stress and adipocyte metabolism contribute to the formation of obesity and diabetes, targeting adipose tissue can be considered as an effective approach to fight against them. Rosiglitazone is used for treatment for patients with type 2 diabetes via inducing lipogenesis and transdifferentiation of white adipose tissue into brown adipose tissue. Since the development of such therapeutics is required to control the formation and function of brown fat cells, we aimed to reveal possible molecular mechanisms behind rosiglitazone induced biochemical changes in the adipose tissue. METHODS: Cells were expanded in the adipocyte culture medium supplemented with 5 µg/mL insulin following 2 days' induction. After those cells were treated with rosiglitazone 0, 0.13 mol/L and 10 µmol/L rosiglitazone for 48 hours and at 8th day, cells were collected and stored at -80 °C. Then the cells were used to evaluate antioxidant enzyme activities, mineral and trace element levels and fatty acid composition. RESULTS: Glucose-6-phosphate dehydrogenase and glutathione reductase significantly reduced in rosiglitazone-treated groups compared to the control. Na, Mg, K, Ca, Cr, Fe, Ni, Cu, Zn, Rb, Sr, Cs, Ba and Pb were determined in the cell lysates via ICP-MS. Also, relative FAME content decreased in the rosiglitazone-treated groups compared to the control. CONCLUSIONS: Rosiglitazone treatment at low doses showed promising results which may promote brown adipose tissue formation. 2020 Duygu Aydemir, Ehsan Sarayloo, Ulusu Nuriye Nuray, published by CEON/CEES.
Entities:
Keywords:
fatty acid; minerals; oxidative stress; rosiglitazone; trace elements
Authors: Serkan Kir; James P White; Sandra Kleiner; Lawrence Kazak; Paul Cohen; Vickie E Baracos; Bruce M Spiegelman Journal: Nature Date: 2014-07-13 Impact factor: 49.962
Authors: Guoqiang Jiang; Qing Dallas-Yang; Zhihua Li; Deborah Szalkowski; Franklin Liu; Xiaolan Shen; Margaret Wu; Gaochao Zhou; Thomas Doebber; Joel Berger; David E Moller; Bei B Zhang Journal: Diabetes Date: 2002-08 Impact factor: 9.461
Authors: Zhaoyun Zhang; Chong Wee Liew; Diane E Handy; Yingyi Zhang; Jane A Leopold; Ji Hu; Lili Guo; Rohit N Kulkarni; Joseph Loscalzo; Robert C Stanton Journal: FASEB J Date: 2009-12-23 Impact factor: 5.191